Dataset from A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Dose-optimization Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007907
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in
adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).
创建时间：
2026-03-25
